Evolving epidemiologic characteristics of invasive group a streptococcal disease in utah, 2002-2010

Clinical Infectious Diseases

Volumn 55, Issue 4, 2012, Pages 479-487

  Stockmann, Chris ^a   Ampofo, Krow ^a   Hersh, Adam L ^a   Blaschke, Anne J ^a   Kendall, Brian A ^b   Korgenski, Kent ^a,c   Daly, Judy ^b   Hill, Harry R ^a,d   Byington, Carrie L ^a   Pavia, Andrew T ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^d ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE SURVEILLANCE; ELECTRONIC MEDICAL RECORD; FEMALE; GROUP A STREPTOCOCCAL INFECTION; HEALTH CARE ORGANIZATION; HUMAN; ICD-9; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENINGITIS; NECROTIZING FASCIITIS; NEWBORN; OSTEOMYELITIS; PERICARDITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RHEUMATIC FEVER; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIA; TOXIC SHOCK SYNDROME; UNITED STATES;

ADOLESCENT; ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; UTAH;

EID: 84864431653     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis422     Document Type: Article

References (37)

1. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853-62.
2. Kaplan EL. The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 1991; 10:55-7.
3. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685-94.
4. Wheeler MC, Roe MH, Kaplan EL, Schlievert PM, Todd JK. Outbreak of group A Streptococcus septicemia in children. Clinical, epidemiologic, and microbiological correlates. JAMA 1991; 266:533-7.
5. Givner LB, Abramson JS, Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J Pediatr 1991; 118:341-6.
6. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 1993; 269:384-9.
7. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
8. Schwartz B, Elliott JA, Butler JC, et al. Clusters of invasive group A streptococcal infections in family, hospital, and nursing home settings. Clin Infect Dis 1992; 15:277-84.
9. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374-82.
10. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol Infect 1988; 100:257-69.
11. Green NM, Zhang S, Porcella SF, et al. Genome sequence of a serotype M28 strain of group a streptococcus: Potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 2005; 192:760-70.
12. Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, group A Streptococcus, 2009. 2010.
13. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002; 35:268-76.
14. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421-7.
15. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124:9-16.
16. Feudtner C, Silveira MJ, Christakis DA. Where do children with complex chronic conditions die? Patterns in Washington State, 1980- 1998. Pediatrics 2002; 109:656-60.
17. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36:8-27.
18. Safar A, Lennon D, Stewart J, et al. Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand, 2005- 2006. Emerg Infect Dis 2011; 17:983-9.
19. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335:547-54.
20. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalen C. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 2005; 10:179-84.
21. Vlaminckx BJ, van Pelt W, Schouls LM, et al. Long-Term surveillance of invasive group A streptococcal disease in The Netherlands, 1994- 2003. Clin Microbiol Infect 2005; 11:226-31.
22. Lepoutre A, Doloy A, Bidet P, et al. Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol 2011; 49:4094-100.
23. Schwartz B, Facklam RR, Breiman RF. Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336:1167-71.
24. Martin DR, Single LA. Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis 1993; 167:1112-7.
25. Veasy LG, Tani LY, Daly JA, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 2004; 113(3 Pt 1):e168-72.
26. Eriksson BK, Andersson J, Holm SE, Norgren M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 1998; 27:1428-36.
27. Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: Risk factors for adults. Emerg Infect Dis 2003; 9:970-7.
28. Factor SH, Levine OS, Harrison LH, et al. Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 2005; 11:1062-6.
29. US Census Bureau. 2010 census summary file 1 Utah: Prepared by the US Census Bureau, 2011.
30. US Census Bureau, Population Division. Table 1. Preliminary annual estimates of the resident population for the United States, regions, states, and Puerto Rice: April 1, 2000 to July 1, 2010 (NST-PEST2010- 01). US Census Bureau, Population Division; 2011.
31. Haddad MB, Porucznik CA, Joyce KE, et al. Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996- 2002. Ann Epidemiol 2008; 18:139-46.
32. U.S. Census Bureau. 2010 Census Summary File 1. Available at: Http ://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf. Accessed 18 June 2011.
33. U.S. Department of Education, National Center for Education Statistics. State nonfiscal survey of public elementary/secondary education, 2000-01 through 2006-07. Available at: Http://nces.ed.gov/programs/digest/d08/tables/dt08-066. asp. Accessed 14 June 2011.
34. Mulla ZD. Invasive group A streptococcal disease and intensive care unit admissions. Intensive Care Med 2002; 28:1822-4.
35. Lamagni TL, Neal S, Keshishian C, et al. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg Infect Dis 2008; 14:202-9.
36. Langley JM, Kellner JD, Solomon N, et al. Empyema associated with community-Acquired pneumonia: A Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2008; 8:129.
37. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30:289-94.